Rapid Therapeutic Science Laboratories, Inc.Rapid Therapeutic Science Laboratories, Inc.Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc.

No trades
See on Supercharts

RTSL fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Rapid Therapeutic Science Laboratories, Inc. operates as an early stage emerging biotech company in the legal hemp and cannabis space. The company develops a new method of formulation and manufacturing to deliver pure CBD, THC, and combinations in legal jurisdictions to consumers. It holds a sublicense agreement to access certain technology regarding the Rxoid metered dose inhaler, which is a medical technology that delivers medication directly to a user's blood stream through the pulmonary tract. It serves customers in the state of Texas. The company was founded on February 22, 2013 and is headquartered in De Leon, TX.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

RTSL does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company